Quadrivalent influenza vaccine (15µg/0.5ml)

· Sinovac Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadrivalent influenza vaccine (15µg/0.5ml), covering 2019-02-27 to 2019-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml) [Phase 3]